4Vote!
Business Wire (Free subscription) | 13 hours ago
FREMONT, Calif.--(BUSINESS WIRE)--Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis....
3Vote!
Medical News Today (Free subscription) | 17 hours ago
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer.
4Vote!
Business Wire (Free subscription) | 11/06/2009
SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009. “Our alliances have continued to achieve strong progress with...
3Vote!
SUGAR SHOCK! Blog (Free subscription) | 11/05/2009
Are you someone who's a fast eater? Well, it's time to slow down, savor your food and take lots of bites. That's advice you can glean from this intriguing new study from the Journal of Clinical Journal of Clinical Endocrinology & Metabolism. Essentially, eating quickly may trigger weight gain, because it curtails the release of hormones (you need) that help regulate your appetite, which could cause...
5Vote!
Red Orbit (Free subscription) | 11/04/2009
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
3Vote!
Medical News Today (Free subscription) | 11/04/2009
Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status. These benefits are present even without changing caloric or nutrient intake.
3Vote!
Medical News Today (Free subscription) | 11/04/2009
Eighteen years ago this month the National Institutes of Health (NIH) announced that it would sponsor a landmark study to examine women and cardiovascular disease. Known as the Women's Health Initiative (WHI), the study enrolled more than 161,000 women. By 2004 however, the government had ended two arms of the study involving estrogen after researchers found it posed a small but detrimental risk for...
3Vote!
Medical News Today (Free subscription) | 11/04/2009
Penn Medicine will lead a new national $45 million clinical trial to test whether testosterone therapy can favorably affect certain conditions affecting older men. Low serum testosterone may contribute to a number of problems affecting older men, including decreased ability to walk, loss of muscle mass and strength, decreased vitality, decreased sexual function, impaired cognition, cardiovascular disease...
6Vote!
Physorg (Free subscription) | 11/04/2009
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). This new information is an important step, say researchers, in understanding...
5Vote!
PharmaGossip (Free subscription) | 11/03/2009
TUESDAY, Nov. 3 ( HealthDay News ) -- Reports about possible kidney problems, including renal failure, in people taking the diabetes drug exenatide (Byetta) have prompted changes to the drug's prescribing information , the U.S. Food and Drug Administration said Monday. From April 2005 to October 2008, the FDA received 78 reports of kidney function problems in patients taking Byetta. Most of the problems...
3Vote!
Medical News Today (Free subscription) | 11/03/2009
A common type of chronic diarrhoea may be caused by a hormone deficiency, according to new research published in the November issue of Clinical Gastroenterology and Hepatology.
3Vote!
good health a challenge 21st century (Free subscription) | 10/30/2009
Diets high in protein promote weight loss and cardiovascular health A recent study focused on the impact of diets high in protein on energy expenditure and satiety. Researchers studied the effects of diets on weight loss, body composition, cardiovascular risk, and blood sugar control. They found that protein induced and promoted energy expenditure and promoted feelings of fullness and satisfaction...
3Vote!
Medical News Today (Free subscription) | 10/29/2009
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women.
3Vote!
newera20 | 01/22/2009
As Majdi Al-Najjar, MD, FACE at the Lakeside Diabetes & Endocrinology Center in Saint Joseph, MI could tell you, type II diabetes is the more common of the two diabetes forms. With type II diabetes, which almost ninety percent of all people suffer...
Videos